Christopher S. Boerner bought $110k of BMY
Chief Executive Officer at BRISTOL MYERS SQUIBB CO. 2,000 shares at an average of $55.05, traded Feb 20, 2025, filed Feb 21, 2025.
Score components
- +25RoleCEO
- +10Trade size$110k at market
- 0Relative to holdingsHoldings up 1.9%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000014272-25-000043, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | POpen-market purchase Common Stock, $0.10 par value | +2,000 | $55.05 | $110k | 104,626 | Feb 21, 2025 |
Related signals
Other insiders at BRISTOL MYERS SQUIBB CO and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | BMYsell BRISTOL MYERS SQUIBB CO | Cristian Massacesi EVP,Chief Med Offr,Head of Dev | $403k 6,249 shares | -25% | |
| 40Moderate | BMYsell BRISTOL MYERS SQUIBB CO | Benjamin Hickey President, RayzeBio Org. | $3,702 97 shares | -100% | |
| 49Moderate | BMYbuy BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $202k 4,250 shares | +5% | |
| 33Weak | BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $100k 1,823 shares | +3% | |
| 25Weak | BMYbuy BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $100k 1,830 shares | +3% | |
| 21Weak | BMYsell BRISTOL MYERS SQUIBB CO | Phil M Holzer SVP and Controller | $39k 700 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.